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Background
Stroke is accompanied by a robust inflammatory
response, glutamate-mediated excitotoxicity, release of
reactive oxygen species and apoptosis. Thiazolidinedi-
ones, which target the nuclear receptor peroxisome prolif-
erator-activated receptor (PPAR)-g, have been reported
recently to exhibit potent anti-inflammatory and anti-oxi-
dant actions and inhibit both neural excitotoxicity and
apoptosis.
Materials and methods
The present study was conducted to determine whether
rosiglitazone, a potent thiazolidinedione for PPAR-g,
would show efficacy against the cerebral infarction and
neurological dysfunctions induced by embolic middle
cerebral artery (MCA) occlusion in the rat. Focal ischae-
mic injury was induced by embolizing a preformed clot
into the MCA. Rosiglitazone was dissolved in dimethyl
sulphoxide and injected i.p. 1 h before MCA occlusion at
doses of 0.033, 0.1, 0.3 or 1 mg/kg. Forty-eight hours after
MCA occlusion, brains were removed, sectioned and
stained with a 2% solution of 2,3,5-triphenyltetrazolum
chloride and analysed using a commercial image-process-
ing software program.
Results
When rosiglitazone was administered 1 h before emboli-
zation, it significantly reduced infarct volume by 48.2,
68.4% and 70.3% at doses of 0.1, 0.3 and 1 mg/kg, respec-
tively (P < 0.001). Rosiglitazone-treated rats also demon-
strated improved neurological functions. However, there
were no statistically significant differences between con-
trol and treated groups in terms of brain oedema at 48 h
after ischaemic injury.
Conclusions
The findings of the present study may support the idea of
a potential benefit of thiazolidinediones in the manage-
ment of ischaemic stroke.
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